DAIMEX Baltic

1st Day - CONFERENCE - DAIMEX Baltic 2026

12 May 2026 | Vilnius, Lithuania

ExpertiseUpdated on 13 April 2026

Rapid Diagnostics & Countermeasures

Director at Lithuanian population and rare disorders biobank

Lithuania

About

Fast validation using real-world data: Access to diverse, well-characterized biospecimens enables rapid testing and benchmarking of diagnostic tools across populations and exposure scenarios.

Translational testing environment: VU MF infrastructure supports end-to-end validation—from biomarker discovery to clinically relevant prototypes, including field-deployable solutions.

Countermeasure development support: Data and samples enable evaluation of vaccines, therapeutics, and response strategies against infectious, toxic, or CBRN-related threats.

Operational impact for defence: Faster deployment of reliable diagnostics; Improved response to biological and hybrid threats; Evidence-based development of medical countermeasures

This creates a dual-use platform for rapid, scalable solutions aligned with NATO preparedness and response priorities.

Organisation

Lithuanian population and rare disorders biobank

Research, Development & Academia

Vilnius, Lithuania

Similar opportunities